Related Experiment Video
Updated: May 17, 2026
Synthesis of an In vivo MRI-detectable Apoptosis Probe
Published on: July 31, 2012
In vitro molecular magnetic resonance imaging detection and measurement of apoptosis using superparamagnetic iron
1Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario P7B 6V4, Canada. rapleyp@tbh.net
Abstract:
Recent research in cell biology as well as oncology research has focused on apoptosis or programmed cell death as a means of quantifying the induced effects of treatment. A hallmark of late-stage apoptosis is nuclear fragmentation in which DNA is degraded to release nucleosomes with their associated histones. In this work, a method was developed for detecting and measuring nucleosome concentration in vitro with magnetic resonance imaging (MRI). The indirect procedure used a commercially available secondary antibody-superparamagnetic iron oxide (SPIO) particle complex as a contrast agent that bound to primary antibodies against nucleosomal histones H4, H2A and H2B. Using a multiple-echo spin-echo sequence on a 1.5 T clinical MRI scanner, significant T₂ relaxation enhancement as a function of in vitro nucleosomal concentration was measured. In addition, clustering or aggregation of the contrast agent was demonstrated with its associated enhancement in T₂ effects. The T₂ clustering enhancement showed a complex dependence on relative concentrations of nucleosomes, primary antibody and secondary antibody + SPIO. The technique supports the feasibility of using MRI measurements of nucleosome concentration in blood as a diagnostic, prognostic and predictive tool in the management of cancer.
Insights
Researchers developed a novel method using magnetic resonance imaging (MRI) to detect nucleosomes, a marker of cell death. This technique shows promise for cancer diagnosis and prognosis by measuring nucleosome levels in blood.
Area of Science:
- Cell Biology
- Oncology
- Biomedical Imaging
Background:
- Apoptosis, or programmed cell death, is crucial for quantifying treatment effects in cancer research.
- Nuclear fragmentation, releasing nucleosomes, is a key indicator of late-stage apoptosis.
Purpose of the Study:
- To develop and validate a magnetic resonance imaging (MRI) method for detecting and quantifying nucleosome concentration in vitro.
- To assess the potential of MRI-based nucleosome measurement as a diagnostic tool in cancer management.
Main Methods:
- An indirect detection method utilizing a superparamagnetic iron oxide (SPIO) particle complex conjugated to antibodies against nucleosomal histones (H4, H2A, H2B).
- Employing a multiple-echo spin-echo sequence on a 1.5 T clinical MRI scanner to measure T₂ relaxation enhancement.
- Investigating the effect of contrast agent aggregation on T₂ relaxation.
Main Results:
- A significant correlation was observed between in vitro nucleosome concentration and T₂ relaxation enhancement.
- Contrast agent clustering demonstrated an associated enhancement in T₂ effects.
- The T₂ clustering enhancement exhibited a complex dependency on the relative concentrations of nucleosomes and antibodies.
Conclusions:
- The developed MRI technique is feasible for detecting and measuring nucleosome concentration.
- MRI measurement of nucleosomes in blood shows potential as a diagnostic, prognostic, and predictive tool for cancer management.
